Will Eli Lilly say “Alzheimer”?

Eli Lilly said “Alzheimer” 1 time on its Aug 5, 2026 call (FY26 Q2), and on 7 of its last 8 calls: 5, 2, 3, 0, 9, 5, 1, 1 times. As of Oct 24, 2026, Eli Lilly said “Alzheimer” on 2 of 2 calls with a settled Kalshi or Polymarket mention market since Feb 4, 2026 (100%), most recently on Aug 5, 2026. Parrot’s p for the next listing is 88% (n=2, from settlement history blended with transcripts), not a forecast.

88%from settlement history blended with transcripts · n=2Next: Earnings call, Oct 29, 2026 · counts: company speakers + operator
Last 10
2/2Last 10 settled, oldest to newest: yes yes
Streak
said the last 2 times
Counts
company speakers + operator
Market
85¢ Kalshi (may be delayed)
Updated

Where it was said

quotes of at most 25 words; select an appearance

Eli Lilly

Alzheimer

Probability
88% · n=2
Settled
2/2 (100%)
Last calls
said in 7 of 8

Next listing counts: company speakers + operator

FY26 Q2 earnings call, Aug 5, 2026 · said 1 time (counts)

Open the appearance

Counts: company speakers + operator

1 counted (1 in prepared remarks, 0 in Q&A).

Lucas Montarcecompanyprepared · 10:05Hear it 10:01, Lucas Montarce In transcript

…to Q2 2025. This is translating to more people being diagnosed with Alzheimer's disease and accessing treatment. Outside the U.S., solid performance in China and…

FY26 Q1 earnings call, Apr 30, 2026 · said 1 time (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

1 counted (1 in prepared remarks, 0 in Q&A).

Lucas MontarcecompanypreparedIn transcript

…amyloid-targeting therapies. The market continues to steadily increase as diagnostic capabilities for Alzheimer's disease expand. We expect European launches to begin contributing to growth…

FY25 Q4 earnings call, Feb 4, 2026 · said 5 times (counts)

Open the appearance

Counts: anyone

5 counted (5 in prepared remarks, 0 in Q&A).

Lucas MontarcecompanypreparedIn transcript

…$109 million, driven by overall market growth, increased awareness and diagnosis of Alzheimer's disease, as well as increased prescriber adoption based on Kisanlo's clinical profile.…

Daniel SkovronskycompanypreparedIn transcript

…major depressive disorder, testing if brenepatide can prevent relapse of disease. In Alzheimer's disease, we continue to look forward to the results from Trailblazer ALS3,…

Every match in the transcript

FY25 Q3 earnings call, Oct 30, 2025 · said 9 times (counts)

Open the appearance

FY25 Q2 earnings call, Aug 7, 2025 · not said

Open the appearance

FY25 Q1 earnings call, May 1, 2025 · said 3 times (counts)

Open the appearance

FY24 Q4 earnings call, Feb 6, 2025 · said 2 times (counts)

Open the appearance

FY24 Q3 earnings call, Oct 30, 2024 · said 5 times (counts)

Open the appearance

Every settled listing

newest first · 2 shown
Every settled listing of this word, newest first
DateListed asVenueResultOur count
Aug 5, 2026AlzheimerKalshiYes1
Feb 4, 2026AlzheimersPolymarketYes5

Questions

How many times did Eli Lilly say “Alzheimer” on its last earnings call?
Eli Lilly said “Alzheimer” 1 time on its Aug 5, 2026 call (FY26 Q2), and on 7 of its last 8 calls: 5, 2, 3, 0, 9, 5, 1, 1 times.
How often does Eli Lilly say “Alzheimer”?
As of Oct 24, 2026, Eli Lilly said “Alzheimer” on 2 of 2 calls with a settled Kalshi or Polymarket mention market since Feb 4, 2026 (100%), most recently on Aug 5, 2026.
What is the probability Eli Lilly says “Alzheimer” next time?
88%, from settlement history blended with transcripts (n=2). It is a base rate from history, not a forecast and not advice.
Who has to say it for the market to count?
Under the next market's rule: company speakers + operator.

Cite parrot.markets, “Eli Lilly: ‘Alzheimer’ mention history”, as of Oct 24, 2026, https://parrot.markets/earnings/LLY/words/alzheimer (CC BY 4.0)

Agents: this page as TSV at /api/v1/word?entity=eli-lilly&word=alzheimer · quotes: /api/v1/quotes?entity=eli-lilly&word=… · columnar JSON in #parrot-data · llms.txt · MCP